A. Bernardo et al., HIV-GP120 AFFECTS THE FUNCTIONAL-ACTIVITY OF OLIGODENDROCYTES AND THEIR SUSCEPTIBILITY TO COMPLEMENT, Journal of neuroscience research, 50(6), 1997, pp. 946-957
The aim of this study was to assess whether the HIV protein gp120 can
induce direct or/and indirect damage to oligodendrocytes (OL). Using h
ighly purified cultures of rat OL, we report that gp120 binds to OL an
d induces functional alterations in these cells. Indeed, the percentag
e of cells expressing myelin basic protein (MBP) and the levels of all
four MBP isoforms were substantially reduced after a 3-day treatment
with 10 nM gp120. As gp120 depressed the ability of OL to reduce the t
etrazolium salt MTT (a sign of mitochondrial impairment), the alterati
on of MBP production may be a consequence of decreased metabolic activ
ity. The above effects were accompanied by a small increase in the num
ber of apoptotic nuclei (from 4.3% in controls to 17.6% in cells treat
ed for 3 days with gp120). As complement can lyse OL and gp120 is know
n to activate complement, we also studied the interaction between thes
e two factors using OL cultures. The viral protein potentiated (by abo
ut 25%) the lytic effect of complement, when administered to the cultu
res 5 hr after complement, and depressed it (by about 30-40%), when ad
ded 5 hr before complement. Heat denaturation and anti-gp120 antibodie
s prevented the direct effect of gp120 on OL, but did not influence th
e interactions between gp120 and complement. Some gp120 non glycosylat
ed peptides (V3 loop, 254-274 and 415-435 peptides) mimicked the abili
ty of gp120 to antagonize the lytic effect of complement, but not that
of potentiating complement lytic activity. In conclusion, our study i
ndicates that gp120 can alter OL functional activity directly and can
interfere with OL susceptibility to complement mediated lysis. (C) 199
7 Wiley-Liss, Inc.